Skip to main content

MoneyWorks4Me

Jenburkt Pharmaceuticals informs about loss of share certificate

30 Jul 2024 Evaluate
Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and disclosure Requirements) Regulations, 2015, Jenburkt Pharmaceuticals has informed about intimation regarding loss of share certificate(s) received on 29th July, 2024, as details enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1904.55
Dr. Reddys Labs. 1376.40
Cipla 1414.00
Lupin 2010.00
Zydus Lifesciences 1207.15
View more..